BDNF is considered relevant in RTT: it has been shown to be dysregulated in both RTT patients (78, 79) and in animal models (80, 81), and its overexpression in mice ameliorates the symptoms of Mecp2-null mice (80). Here, MECP2 is linked to Rett syndrome.